Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,562 | 8,898 | 5,088 | -2,240 | -9,279 |
| Depreciation Amortization | 1,345 | 1,435 | 1,525 | 1,511 | 1,257 |
| Income taxes - deferred | N/A | -2,172 | N/A | N/A | N/A |
| Accounts receivable | -37 | 439 | 611 | -2,785 | -546 |
| Other Working Capital | -2,026 | -1,010 | -2,058 | -3,207 | -990 |
| Other Operating Activity | 494 | -1,081 | -1,972 | 4,928 | 2,765 |
| Operating Cash Flow | $3,339 | $6,508 | $3,194 | $-1,794 | $-6,793 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,737 | -499 | -263 | -35 | -19 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | 350 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 350 |
| Investing Cash Flow | $-5,737 | $-499 | $-263 | $-35 | $331 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,439 | N/A | 1,014 | N/A | N/A |
| Debt Repayment | -12,240 | N/A | -105 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 42 | 1,438 | 2,064 |
| Other Financing Activity | -497 | -667 | -1,821 | -749 | -497 |
| Financing Cash Flow | $1,702 | $-667 | $-870 | $690 | $1,567 |
| Beginning Cash Position | 8,940 | 3,598 | 1,537 | 2,676 | 7,571 |
| End Cash Position | 8,245 | 8,940 | 3,598 | 1,537 | 2,676 |
| Net Cash Flow | $-696 | $5,343 | $2,061 | $-1,139 | $-4,895 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,339 | 6,508 | 3,194 | -1,794 | -6,793 |
| Capital Expenditure | -5,737 | -499 | -330 | -35 | -19 |
| Free Cash Flow | -2,398 | 6,010 | 2,864 | -1,829 | -6,812 |